Back to Trades
Bodenstedt Matthias
Chief Financial OfficerCIK 0001920545
Profile
- Filings
- 7
- Buy transactions
- 1
- Sell transactions
- 7
- Companies
- 1
- Active
- 2025–2026
Bodenstedt Matthias, Chief Financial Officer, has filed 7 SEC reports (2025–2026), all concentrated in MoonLake Immunotherapeutics (MLTX), totaling $3.3M in disclosed volume. Weighing $98.8K bought versus $3.2M sold, the history is heavily weighted toward selling. The largest single open-market purchase on record is $98.8K in MoonLake Immunotherapeutics. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Jun 23 | MLTX MoonLake Immunotherapeutics | Bodenstedt Matthias | Chief Financial Officer | Sell | $862.2K |
| Jun 18 | MLTX MoonLake Immunotherapeutics | Bodenstedt Matthias | Chief Financial Officer | Sell | $351.6K |
| May 13 | MLTX MoonLake Immunotherapeutics | Bodenstedt Matthias | Chief Financial Officer | Sell | $273.3K |
| Apr 16 | MLTX MoonLake Immunotherapeutics | Bodenstedt Matthias | Chief Financial Officer | Sell | $47.5K |
| Apr 10 | MLTX MoonLake Immunotherapeutics | Bodenstedt Matthias | Chief Financial Officer | Sell | $1.7M |
| Dec 22 | MLTX MoonLake Immunotherapeutics | Bodenstedt Matthias | Chief Financial Officer | Conversion | $0 |
| Oct 9 | MLTX MoonLake Immunotherapeutics | Bodenstedt Matthias | Chief Financial Officer | Buy | $98.8K |
7 filings